An innovative solution for management of respiratory conditions: Smart inhaler
smart inhalers market, based on the product, was segmented as, nebulizers and inhalers. In 2018, the inhalers held the largest share of the market, by product. In addition, the segment is also anticipated to grow at a significant rate during the forecast period. Inhalers are widely used in respiratory disorders such as asthma and COPD. They are available in various forms such as manually-actuated pressurized metered-dose inhalers, breath-actuated pressurized metered-dose inhalers, dry powder inhalers, and mist inhalers. The use of the type of inhaler highly depends on the intensity of the respiratory disorder and the need for its diagnosis.
Download Sample Copy Of Smart Inhalers
The cases of asthma and COPD has been increasing across the globe at a significant rate. During recent years, there has been a rise in the number of smokers as well as air pollution in developed as well as developing countries across the globe. As per estimates provided by the WHO, there are currently 235 million people suffering from asthma across the globe. As per the Centers for Disease Control and Prevention (CDC), the number of adults above 18 years of age currently having asthma is approximately 19 million in the United States, accounting for almost 7.7% of the total adult population. Whereas, the number of individuals below 18 years of age suffering from asthma is 6.2 million, accounting for 8.4% of the total children population. Also, as per the WHO estimates published during December 2016, there were 383 000 deaths due to asthma in 2015.
There have been limited developments made in the smart inhalers market during recent years. However, growth strategies such as approvals, collaborations, and partnerships have been witnessed in the market of smart inhalers. For instance, during July, 2018 Adherium received FDA approval for its Hailie sensor, which can be used along with ProAir HFA, Ventolin HFA, and Flovent HFA asthma inhalers. Also, during August 2018, Novartis AG and Propeller Health entered into a collaboration for the development of custom add-on sensor for the Breezhaler inhaler, a device intended to be used for the treatment of COPD.
Inhalers segment is expected to grow the market for smart inhalers over the forecast period for product segment.The major players operating in the smart inhalers market include GlaxoSmithKline plc, Adherium Ltd., Vectura Group plc, Novartis AG, Findair Sp. z o. o., Cohero Health, Crux Product Design Ltd, Teva Pharmaceuticals, 3M, and Amiko Digital Health Limited.